Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Contraceptives Market to 2017 - Executive Summary
2.1 High Growth Rate and Increasing Awareness Have Made Contraceptive Market Attractive
2.2 Strong Pipeline and the Entry of New Companies Will Intensify Competition
2.3 Strategic Consolidations Have Led to the Entry of New Companies in the Contraceptives Market
3 Contraceptives Market to 2017- Introduction
3.1 GBI Research Report Guidance
4 Contraceptives Market to 2017 - Market Overview
4.1 Introduction
4.2 Revenue Forecasts for Contraceptives Market
4.2.1 Revenues
4.2.2 Annual Cost of Usage for Contraceptives
4.2.3 Share of Prescription and OTC Contraceptives
4.3 Drivers and Barriers for Contraceptives Market
4.3.1 Drivers for Contraceptives
4.3.2 Barriers for Contraceptives
5 Contraceptives Market to 2017- Geographical Landscape
5.1 The US
5.1.1 Revenue
5.1.2 Annual Cost of Therapy for Contraceptives
5.2 Top Five Countries of Europe
5.2.1 Revenue
5.2.2 Annual Cost of Therapy for Contraceptives
5.3 Japan
5.3.1 Revenue
5.3.2 Annual Cost of Therapy for Contraceptives
6 Contraceptives Market to 2017 – Therapeutic landscape
6.1 Oral Contraceptives
6.1.1 Introduction
6.1.2 Revenue
6.1.3 Annual Cost of Therapy
6.1.4 Treatment Usage Patterns
6.2 Injectables
6.2.1 Introduction
6.2.2 Revenue
6.2.3 Annual Cost of Therapy
6.2.4 Treatment Usage Patterns
6.3 Topical Contraceptives
6.3.1 Introduction
6.3.2 Revenue
6.3.3 Annual Cost of Therapy
6.3.4 Treatment Usage Patterns
7 Contraceptives Market to 2017 – Devices landscape
7.1 Vaginal Ring
7.1.1 Introduction
7.1.2 Revenue
7.1.3 Geographical Segmentation
7.1.4 Annual Cost of Usage
7.2 Intrauterine Devices
7.2.1 Introduction
7.2.2 Revenue
7.2.3 Copper Intrauterine Device and Hormonal Intrauterine Device Share
7.2.4 Geographical Segmentation
7.2.5 Annual Cost of Usage
7.3 Condoms
7.3.1 Introduction
7.3.2 Revenue
7.3.3 Geographical Segmentation
7.3.4 Annual Cost of Usage
8 Contraceptives Market to 2017 – Pipeline Analysis
8.1 Introduction
8.2 Profiles of Promising Drugs in the Global Contraceptives Market
8.2.1 AG200-15
8.2.2 Yaz Flex
8.2.3 Pill-Plus
9 Contraceptives Market to 2017 – Competitive Landscape
9.1 Market Share Analysis: Contraceptives Market
9.2 Drug Profile of Major Marketed Contraceptives
9.2.1 Yaz/ Yasmin
9.2.2 Mirena
9.2.3 Nuvaring
9.3 Competitive Profiling
9.3.1 Bayer
9.3.2 Johnson & Johnson
9.3.3 Church & Dwight
9.3.4 Merck
9.3.5 Reckitt & Benckiser
10 Contraceptives Market to 2017 - M&A Landscape
10.1 M&A Landscape
10.1.1 M&A Deals by Year
10.1.2 M&A Deals by Value
10.1.3 M&A Deals by Geography
10.1.4 M&A Deals by Deal Type
10.1.5 M&A Deals by Deal Sub-Type
10.2 R&D Licensing Agreements
10.2.1 Deals by Year
10.2.2 Deals by Geography
10.2.3 Deals by Value
10.3 Co-Development Agreements
10.3.1 Deals by Year
10.3.2 Deals by Geography
11 Contraceptives Market to 2017 – Appendix
11.1 Market Definitions
11.2 Abbreviations
11.3 Research Methodology
11.3.1 Coverage
11.3.2 Secondary Research
11.3.3 Primary Research
11.3.4 Section Methodology
11.3.5 Expert Panel Validation
11.4 Contact Us
11.5 Disclaimer
11.6 Sources